times higher than it is today (see go.nature. com/3dd66bw).
For Han, the realization among policymakers in the time since she's moved back to China that the country's health-care system needs to change to cope with the unprecedented demand from elderly citizens has provided momentum for her work. In around 2015, funding agencies in China started to enlist scientists to discuss and propose strategies to address the challenges from population ageing, she says, and that has led to the initiation of dedicated grant tracks and an ever-growing ageing-research community.
Han spent the first five years back in China exploring how genes interact during the ageing process, before being asked in 2010 to lead a pilot project in Shanghai. The Partner Institute for Computational Biology, a collaboration between the Chinese Academy of Sciences (CAS) and the German Max Planck Society, uses computational methods to extract patterns from huge gene and protein data sets to better understand how our cells and body age, among other goals.
In 2015, after publishing numerous studies about ageing in worms and mice, Han and her team published their first work in humans, based on a relatively small cohort of 300 people. It showed how algorithms can use 3D facial images to predict how fast a person is ageing (W. Chen et al. Cell Res. 25, 574-587; 2015) . She also secured a grant of 1.9 million yuan (US$270,000) from the Ministry of Science and Technology (MOST). Then, last July, she moved to Peking University in Beijing, and now hopes to publish work on 5,000 individuals.
Ageing research is still very much an up-and-coming field, says Han, but "even if you can't provide startling results right now or immediately describe how it will be applied, ageing-related research needs to be done urgently in the social context of China".
A new field for old problems
Between 2008 and 2018, the number of papers on geriatrics and gerontology published by researchers at Chinese institutions tripled. In 2016, the Chinese government announced the Healthy China 2030 plan, a national policy to address the country's long-term health-care challenges. The policy includes a range of interventions to promote health in elderly people, such as encouraging a balanced diet and better fitness, and discouraging smoking.
In the same year, the director of the CAS All these efforts are designed to push the development of services and research for senior citizens in China forwards, says Weiping Jia, who runs the Shanghai Institute of Diabetes at Shanghai Jiao Tong University.
The government has also funded centres for basic and clinical ageing research, including the CAS Institute of Stem Cell and Regeneration and the Aging Research Center at Peking University, both in Beijing.
However, James Kirkland, head of the Robert and Arlene Kogod Center on Aging at the Mayo Clinic in Rochester, Minnesota, says that more commitment might be needed, given the size of the problem.
"I think they're on a knife-edge," he says. "Is this going to be one of the scientific challenges they invest in heavily, or perhaps they'll focus on another research area, such as some form of new space exploration? I don't think they've made that key decision yet to push this kind of systems biology forward as a critical priority."
Geriatrics scientists in China are keen to tap into the country's massive and homogeneous population by using large-scale studies to generate reliable data on how people age.
Stroke prevalence per 100,000 people
AGE ASSOCIATED DISEASES
As China's population ages, the country must treat more people with strokes, among other health issues. The proportion of the population aged over 65 is expected to reach 24% by 2050. In 1997, 6% of the population was over 65.
In 2007, 8% of population was over 65. Here he speaks to Nature about his research into age-related hearing loss, and explains why he hopes that brain training could help to lessen declines in sensory perception generally, and so ward off neurodegenerative diseases.
What is your current research focus?
We want to better understand the neural basis for why a person's hearing function declines as they grow older. For example, we have performed research to see whether we can reverse age-related changes to the auditory systems of rodents.
We gave the animals a set of tasks, such as learning to discriminate between sounds of different frequencies or intensities. These exercises caused the rodents' hearing to improve, and also promoted changes to the hippocampus, a part of the brain structure closely associated with learning and memory.
The relationship with the hippocampus suggests that new kinds of brain training might help to attenuate our declines in perception and other brain functions, such as learning and memory, as we grow older -and so have the potential to stave off neurodegenerative diseases.
How is ageing-related science developing in China?
As has happened in the rest of the world, a rapidly ageing population has brought significant concern to policymakers. However, as far as I know, only a few neuroscience laboratories in China are specifically focused on learning more about the underlying mechanisms that cause changes in brain function as we age. This is despite the fact that such research could have a considerable impact on the welfare of older people in the future.
Nevertheless, the volume of research carried out in China in this area has increased dramatically -probably because of the huge growth of the country's scientific community as a whole in recent years, but also because funding for neuroscience research has risen.
In what areas of ageing-related research is
Chinese science making most progress? I think we could make the most progress in our research on Alzheimer's disease, a neurodegenerative disorder that causes difficulties with memory, cognition and behaviour in many older people. It is one of three brain-related diseases that will be the focus of a forthcoming national neuroscience initiative called the China Brain Project.
So it is foreseeable that a considerable number of Chinese scientists in related fields, such as neuroscience, medicine and artificial intelligence, will work together as part of this plan to study the mechanisms of Alzheimer's. Of course, it's hoped that these studies will receive huge financial support from the central government, and this should help to propel our research.
What needs to happen for China to make greater leaps in scientific research?
The environment for scientific research, including the management of staff, academic evaluation and financial support, needs to be further improved. For example, researchers spend a lot of valuable time doing administrative work, such as making applications for new instruments and organizing their expenses -time that would be better spent on scientific research, I think.
Fortunately, the management team at my university has noticed this problem and has made a big effort to solve it, and the situation is now gradually improving. In the field of brain science, many Chinese scientists also need more opportunities to collaborate with our international peers to help advance our research. Patience and persistence are very important, too, of course.
Interview by Sarah O'Meara.
This interview has been edited for length and clarity.
Xiaoming Zhou Neurobiologist
The nation has already prioritized the use of big data and artificial intelligence in medicine. Its Healthy China plan, for example, will involve building more data centres to collect and combine medical records that are currently spread across separate departments.
National investment
In 2018, MOST awarded 15 million yuan to Piu Chan, director of the Chinese National Clinical Research Center for Geriatric Disorders at Xuanwu Hospital, Capital Medical University, in Beijing. The grant was so that Chan, a neurologist who researches Parkinson's disease, could use patients' electronic medical records to build a national database of information about neurodegenerative conditions. Given that nearly 60% of people with Parkinson's live in China, that could become a valuable resource for researchers around the world.
Chan is now working with biologist Gang Pei, who is at Tongji University in Shanghai and researches drugs that could reduce the effects of Alzheimer's disease on cognitive decline, to get the database off the ground. It can be tough to convince different government offices to share information, Pei says, because there is little precedent for this kind of national collaboration. "We need to all agree on the rules of how data are shared, how they will be used, what form they come in and who will receive the benefit of any scientific achievement," he says.
Pei would also like to see China develop a repository for tissue samples that can be used by neuroscientists and clinical researchers throughout the nation, as well as worldwide, but says that's likely to be stymied by the stigma attached to organ donation in the country.
"We don't have this tradition. We think the body is sacred. So we need to teach people why they should agree to donate their body to medical science for the greater good."
Guanghui Liu, a stem-cell researcher at the CAS Institute of Stem Cell and Regeneration in Beijing and president of the Chinese Society of Aging Cell Research, says that as well as overcoming cultural challenges, research areas will need to be integrated better if the field is to make progress. "In China, we need cross-disciplinary integration of areas such as biomedicine, physics, chemistry, engineering, bioinformatics and artificial intelligence," he says. "That's probably our greatest challenge to promote the development of the field." Sarah O'Meara is a freelance journalist based in London. Additional research by Kevin Schoenmakers.
